Focus Graphite Engages Dr. Reuter Investor Relations to Expand German and European Capital Markets Presence

Core Viewpoint - Focus Graphite Inc. has engaged Dr. Reuter Investor Relations to enhance its visibility and communications in the European capital markets, effective February 16, 2026, amid growing interest in secure critical minerals supply chains, particularly for battery materials and defense applications [1][2][3]. Company Engagement and Strategy - The engagement with Dr. Reuter aims to improve investor awareness and shareholder communications as the company advances its flagship projects and downstream processing initiatives [2][3]. - Focus Graphite's CEO highlighted the increasing strategic interest from European markets in diversifying supply chains for critical minerals, emphasizing the need for secure and traceable graphite supply [3]. - The company will participate in the Canadian Critical Minerals Mission to Europe from February 16-20, 2026, facilitating direct dialogue with government stakeholders and institutional investors [4]. Financial Terms of Engagement - The agreement with Dr. Reuter includes a monthly fee of €4,000 for a six-month term, with a performance review after three months [5]. - The services provided will encompass investor relations, financial public relations, and ongoing performance reporting [5]. Company Overview - Focus Graphite Advanced Materials operates two 100% owned graphite projects, with the Lac Knife project being one of the most advanced high-purity graphite deposits in North America [6][7]. - The company is committed to environmentally sustainable processing solutions and innovative battery technologies, including a patent-pending silicon-enhanced spheroidized graphite [7][8]. - Focus Graphite aims to secure a locally sourced supply of critical minerals, reducing dependence on foreign markets and driving the transition to a sustainable future [8].